GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| EBITDA (TTM) | 5-year CAGR | 10-year CAGR |
|---|---|---|
| −$2.1B | 19.0% | −7.4% |
| EBITDA (TTM) | −$2.1B |
|---|---|
| 5-year CAGR | 19.0% |
| 10-year CAGR | −7.4% |
EBITDA
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $10.4B | +408.7% |
| 2024 | $2.0B | −74.3% |
| 2023 | $8.0B | +4.0% |
| 2022 | $7.7B | −25.3% |
| 2021 | $10.2B | +135.1% |
| 2020 | $4.4B | −4.0% |
| 2019 | $4.5B | −46.1% |
| 2018 | $8.4B | −41.3% |
| 2017 | $14.4B | −19.4% |
| 2016 | $17.8B | −20.3% |
| 2015 | $22.4B | +45.3% |
| 2014 | $15.4B | +232.6% |
| 2013 | $4.6B | +13.0% |
| 2012 | $4.1B | +6.0% |
| 2011 | $3.9B | −4.2% |
| 2010 | $4.0B | +12.1% |
| 2009 | $3.6B | +31.6% |
| 2008 | $2.7B | +24.0% |
| 2007 | $2.2B | — |